Journal Articles Alzheimer's & Dementia : the Journal of the Alzheimer's Association Year : 2021

Prediction of amyloid pathology in cognitively unimpaired individuals using structural MRI

Irene Cumplido‐mayoral
  • Function : Author
Silvia Ingala
  • Function : Author
Luigi Lorenzini
  • Function : Author
Alle Meije Wink
  • Function : Author
Sven Haller
  • Function : Author
Jose Molinuevo
  • Function : Author
Robin Wolz
  • Function : Author
Alessandro Palombit
  • Function : Author
Adam J. Schwarz
  • Function : Author
Pierre Payoux
Pablo Martinez‐lage
  • Function : Author
Giovanni Frisoni
  • Function : Author
Nick C Fox
  • Function : Author
Craig W. Ritchie
  • Function : Author
Joanna M Wardlaw
  • Function : Author
Adam Waldman
  • Function : Author
Frederik Barkhof
  • Function : Author
Verónica Vilaplana
  • Function : Author
Juan Domingo Gispert
  • Function : Author

Abstract

AbstractBackgroundStructural MRI measurements can contribute to the prediction of amyloid pathology in cognitively unimpaired (CU) individuals. In this work, we aimed at studying the predictive capacity, robustness, and generalizability of ML techniques to predict amyloid‐β pathology in CU individuals, as well as identifying key brain regions contributing to this prediction.MethodWe included 653 and 250 CU individuals from the EPAD and ADNI studies, respectively, with available T1w MRI and CSF Aβ42 measurements. Subjects were categorized as amyloid‐β positive (Aβ+) or negative (Aβ‐) according to established cut‐offs (CSF Aβ42<1000pg/mL for EPAD and <880pg/mL for ADNI). Volumes and cortical thickness in regions of the Desikan‐Kiliany atlas were obtained with Freesurfer 6.0, as well as the Total Intracranial Volume (TIV). We trained XGBoost classifiers to predict amyloid‐β positivity using age, sex, education, MMSE, APOE‐ɛ4 status, volumes/TIV, and cortical thickness measurements. To study the generalizability of the classifier, we performed within‐cohorts classification (train and test within the same cohort); and between‐cohorts classification (train with one cohort and test with another). We performed the latter classification, both with the original samples, and following a bootstrapping approach to force balanced data in the training. With the classification results, we conducted a ROC analysis and, additionally, calculated SHAP values to determine the most important brain regions used to predict Aβ+.ResultSimilar classification performance was achieved when training/testing within ADNI (ROC‐AUC=0.72 (0.59‐0.84)) and within EPAD (ROC AUC=0. 68 (0.60‐0.76)) (Figure 1A). In the between cohort’s analysis, ROC‐AUC decreased slightly in both cases (Figure 1B) but was consistent over subsampling of individuals. Train with ADNI and test with EPAD gave ROC‐AUC=0.61 (0.58‐0.64) and train with EPAD and test with ADNI gave ROC‐AUC=0.59 (0.54‐0.66). The most important features used for prediction were similar for both ADNI and EPAD (Figure 2). The increased volume and/or thickness of some brain regions, such as superior frontal areas, predicted Aβ+. The decrease in cingulate cortex was also seen. APOE‐ɛ4 status also had a high impact on classification performance.ConclusionThe use of structural MRI measurements in combination with Machine Learning can provide additional capacity to predict amyloid‐β status in CU individuals.

Fichier principal
Vignette du fichier
AAIC2021_Amyloid_prediction.pdf (800.94 Ko) Télécharger le fichier
Origin Files produced by the author(s)
Licence

Dates and versions

hal-04905380 , version 1 (22-01-2025)

Licence

Identifiers

Cite

Irene Cumplido‐mayoral, Silvia Ingala, Luigi Lorenzini, Alle Meije Wink, Sven Haller, et al.. Prediction of amyloid pathology in cognitively unimpaired individuals using structural MRI. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2021, 17 (S4), ⟨10.1002/alz.053661⟩. ⟨hal-04905380⟩
53 View
56 Download

Altmetric

Share

  • More